drugset / Trial / NCT01825928

An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence

NCT01825928

Completed 80 enrolled Wei Hao
RandomizedParallel-groupDouble-blindTreatment

Summary

Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. paliperidone are Second generation antipsychotics,and have effects of blocking dopamine2(D2) and 5-hydroxytryptamine 2A(5-HT) receptors neurotransmitters.To determine whether mirtazapine would reduce methamphetamine use among methamphetamine addicts.

Timeline

Start
2013-02
Primary completion
2014-04
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Paliperidone Unknown 3 mg